AviadoBio

Contact

CONTACT We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here For General Enquiries For Patients and...

Careers

CAREERS When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission   Life at AviadoBio Open...

Science & Delivery

SCIENCE & DELIVERY Find out more about how we are progressing innovative gene therapies to potentially treat neurodegenerative disease.  Science & Delivery Pipeline Delivery FTD ALS Publications &...

About Us

ABOUT US Learn more about our mission to transform lives and our industry-leading team About Us Leadership Team Board of Directors Scientific Advisory...

ABOUT US

Learn more about our mission to transform lives and our industry-leading team

SCIENCE & DELIVERY

Find out more about how we are progressing innovative gene therapies to potentially treat neurodegenerative disease. 

CAREERS

When you join AviadoBio, you join more than just a company, you join a dedicated team with a clear mission

 

CONTACT

We’d love to hear from you. If you have an enquiry about our gene therapies, delivery systems or clinical trials please contact us using the details here

 

A Phase 1/2 open-label clinical study to evaluate the safety and preliminary efficacy of AVB-101 in people with a genetic sub-type of frontotemporal dementia (FTD-GRN) is now open for enrollment.